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Introduction
Diffuse  normolipaemic  plane  xanthoma  is  a  rare  form  of  xantho-
ma  usually  associated  with  an  underlying  haematological  or 
inflammatory  condition,  and  may  present  many years  prior  to 
the  onset  of  systemic  illness.  We  present  a  case  of  this  uncom-
mon  condition  occurring  in  association  with  a  monoclonal  gam-
mopathy  of  unknown  significance.
Case study
A 74-year-old Caucasian male presented with diffuse yellow- 
orange skin discolouration, which had progressed over the 
preceding few months. There was no medical history of note, 
and he was not taking any medication. There was no family 
history of dyslipidaemia or premature cardiovascular disease. On 
examination, the patient was found to be clinically well, but had 
diffuse mildly raised yellow-orange skin dicolouration of his face, 
neck, arms, chest and back (Figure 1). Arcus cornealis was not 
visible, and there was no palpable tendon xanthomata.
Initial laboratory tests, which included renal and liver function, 
calcium, phosphate and urate, thyroid function and glucose lev-
els, as well as a complete blood count, were within normal limits. 
The fasting lipid profile showed only mild hyperlipidaemia, with 
a total serum cholesterol level of 5.4  mmol/l, triglycerides of 
1.2  mmol/l, high-density lipoprotein (HDL) cholesterol of 
1.3 mmol/l and calculated low-density lipoprotein (LDL) choles-
terol of 1.3 mmol/l. A skin biopsy indicated groups of lipid-laden 
foamy histiocytes in the dermis and perivascular areas, with no 
evidence of necrobiosis or Touton cells, in keeping with diffuse 
normolipaemic planar xanthomatosis (DNPX) (Figure 2). The 
erythrocyte sedimentation rate was 76 mm/hour and an immu-
noglobulin G kappa monoclonal band was demonstrated on 
serum protein electrophoresis. The urine was negative using the 
Bence-Jones protein test. Both the chest radiograph and an 
abdominal ultrasound were unremarkable. The eletrocardio-
gram showed a normal tracing. A bone marrow aspirate and tre-
phine biopsy demonstrated a variably cellular bone marrow 
with < 10% plasma cells, suggestive of a monoclonal gammopa-
thy of unknown significance (MGUS).
These findings are consistent with a diagnosis of DNPX, associated 
with MGUS. The patient was started on atorvastatin 20 mg daily 
for his mild hyperlipidaemia, and did not require specific therapy 
for the skin lesions. There was some resolution of the skin lesions 
on statin therapy, and he continues to follow-up routinely at our 
facility.
Discussion
Also called generalised planar xanthomatosis, DNPX is a rare 
form of xanthoma which occurs as a macular yellow-orange or 
yellow-brown skin discolouration, and is most commonly seen in 
a symmetrical distribution over the upper torso and neck, 
though rarely as extensively as in our patient. These xanthomata 
were originally thought to occur idiosyncratically because of 
Figure 1: Xanthomata, featuring extensive involvement of the chest, upper 
limbs and face
Figure 2: The haematoxylin and eosin findings; a skin biopsy 
demonstrating intradermal and perivascular infiltration by foamy 
histiocytes (arrows) (magnification × 200)
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their association with normal serum lipid levels. However, many 
of these patients subsequently developed paraproteinaemia or 
dysglobulinaemia.1 In addition to MGUS, multiple myeloma, leu-
kaemia, adult T-cell lymphoma, cryoglobulinaemia, rheumatoid 
arthritis, Takayasu’s arteritis and eosinophilic granulomatosis 
have all been described as being associated with the condition.1,2 
The skin lesions may precede the haematological or systemic dis-
order by many years. The cause of the xanthomatous deposition 
within the skin is not well understood, but a number of theories 
have been proposed. According to the most plausible theory, the 
monoclonal immunoglobulin binds with apolipoprotein B-100 
on the LDL particles at a site remote from the LDL receptor-bind-
ing site. This does not result in a change in affinity for the LDL re-
ceptor, but in an increased affinity for the acetyl LDL receptor, 
enhancing macrophage uptake and esterification, and resulting 
in cutaneous xanthomata with normolipaemia.3,4
Conclusion
This case illustrates the occurrence of DNPX in association with a 
monoclonal gammopathy of unknown significance. Although a 
rare form of xanthomatosis, this condition often heralds an 
underlying haematological or systemic condition, and highlights 
the need to search for such conditions.
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